Compounds > uk 68798
Page last updated: 2024-08-25

uk 68798 and Chronic Disease

uk 68798 has been researched along with Chronic Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akerman, S; Dixit, S; Epstein, AE; Frankel, DS; Khurshid, S; Man, JP; Marchlinski, FE; Supple, G1
Shah, Y; Steinberg, JS; Szepietowska, B1
Csanády, M; Csík, N; Farkas, A; Farkas, AS; Forster, T; Fülöp, F; Makra, P; Orosz, S; Papp, JG; Shattock, MJ; Varró, A1
Garikipati, NV; Kamath, GS; Khan, A; Marrero, D; Mittal, S; Steinberg, JS1
Beekman, JD; Chamberlin, P; der Nagel, Rv; Dittrich, HC; Oros, A; Stams, TR; Vos, MA1
Akhtar, M; Narayan, G; Sra, J1
Vergara, G1
Boyden, PA1
Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C1

Trials

1 trial(s) available for uk 68798 and Chronic Disease

ArticleYear
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Circulation, 2001, Jul-17, Volume: 104, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left

2001

Other Studies

8 other study(ies) available for uk 68798 and Chronic Disease

ArticleYear
Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2015, Volume: 42, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Cohort Studies; Disease-Free Survival; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Phenethylamines; Predictive Value of Tests; Proportional Hazards Models; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome

2015
Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation.
    Pacing and clinical electrophysiology : PACE, 2017, Volume: 40, Issue:6

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Causality; Chronic Disease; Cohort Studies; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; New York; Phenethylamines; Retrospective Studies; Risk Factors; Sulfonamides; Torsades de Pointes; Treatment Outcome

2017
The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.
    British journal of pharmacology, 2009, Volume: 156, Issue:6

    Topics: Animals; Calcium Channels, L-Type; Chronic Disease; Coronary Circulation; Female; Heart Block; Heart Rate; In Vitro Techniques; Phenethylamines; Potassium Channel Blockers; Rabbits; Sodium Channels; Sodium-Calcium Exchanger; Sulfonamides; Torsades de Pointes

2009
Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling.
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:2

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Female; Heart Conduction System; Humans; Male; Middle Aged; Phenethylamines; Pulmonary Veins; Sulfonamides; Treatment Outcome

2011
Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    European journal of pharmacology, 2011, Dec-15, Volume: 672, Issue:1-3

    Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Chronic Disease; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Female; Male; Membrane Potentials; Phenethylamines; Sulfonamides; Thiazepines; Time Factors; Torsades de Pointes

2011
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2006, Volume: 15, Issue:3

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female; Flecainide; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Secondary Prevention; Sotalol; Sulfonamides; Treatment Failure; Treatment Outcome

2006
[Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:3

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides

2001
Three things you should know when considering the atria: location, location, location.
    Circulation research, 2001, Jun-08, Volume: 88, Issue:11

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cation Transport Proteins; Chronic Disease; Disease Progression; DNA-Binding Proteins; Dogs; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart Atria; Heart Conduction System; Mice; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Sulfonamides; Trans-Activators

2001